Inverse agonist activity at the α2A-adrenergic receptor

Molecular Pharmacology

Volumn 59, Issue 3, 2001, Pages 532-542

  Wade, Susan M ^a   Lan, Keng Li ^a   Moore, Dorian J ^a   Neubig, Richard R ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; IDAZOXAN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PHENTOLAMINE; RAUWOLSCINE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; YOHIMBINE;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION;

EID: 0035119522     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.3.532     Document Type: Article

References (40)

1. Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands
2. 2C receptor systems
3. 2-adrenoceptor
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. 2A-adrenergic receptor signaling in CHO cells. l-Isoproterenol selectively activates G
6. Homologous regulation of the α2C-adrenoceptor subtype in human hepatocarcinoma, HepG2
7. Use of constitutive G protein-coupled receptor activity for drug discovery
8. 50) of an enzymatic reaction
9. Inverse agonist activity ofβ-adrenergic antagonists
10. 1A receptors in human cerebral cortex
11. Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins
12. Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: Specific regulation by antagonists and sodium ions
13. 2-adrenergic receptors
14. 5
15. 1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla
16. 2-adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines
17. Agonist-receptor efficacy. II. Agonist trafficking of receptor signals
18. 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation
19. 2-adrenergic receptor in membrane and solubilized preparations
20. 2a-adrenergic receptor subtype
21. 1-imidazoline receptors in rat brain
22. 2-adrenoceptor activation
23. 2-adrenergic receptors in purified membranes from human platelets: Implications of receptor-inhibitory nucleotide binding protein stoichiometry
24. 2 adrenergic receptors: Evidence for a precoupled receptor-guanine nucleotide protein complex
25. Blood pressure and blood pressure variability following withdrawal of propranolol and clonidine
26. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
27. Review: Amino acid domains involved in constitutive activation of G-protein-coupled receptors
28. Constitutive activation of a single effector pathway: Evidence for multiple activation states of a G protein-coupled receptor
29. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness
30. 2-adrenergic receptor
31. A highly sensitive adenylate cyclase assay
32. 2-adrenergic receptor. Extending the ternary complex model
33. 2-adrenergic receptor
34. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty
35. 2-adrenergic receptor activation of G proteins: Evidence for a precoupled receptor/G protein state
36. s activation
37. The cubic ternary complex receptor-occupancy model. III. Resurrecting efficacy
38. 2-dopamine receptor of the anterior pituitary gland
39. 2A adrenergic receptors